Home » Topics » Conferences

Conferences
RSS

Astra presents results of first human trial of AR-C69931MX at ACC meeting

March 11, 1999

Dual vasopeptidase inhibition provides considerable therapeutic benefit in heart failure

March 11, 1999

Viable myocardium can be detected using SHU-563A for contrast enhancement

March 11, 1999

Nesiritide improves symptoms, hemodynamics in both moderate and severe CHF

March 11, 1999

Ultrasound imaging enhanced with AI-700 provides accurate assessment of CV disorders

March 10, 1999

Enbrel advances to phase II/III trials for chronic heart failure; phase I results presented at ACC

March 10, 1999

Corvas presents phase I trial results of novel injectable anticoagulant at ACC meeting

March 9, 1999

Spotlight on double and triple enzyme inhibitors for treating cardiovascular disease

Feb. 24, 1999

Renal protective effects of azelnidipine involve inhibition of AGE production

Feb. 22, 1999

Antihypertensive effects of bradykinin agonist FR-190997 evaluated in animals

Feb. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...